Skip to main content
Access Resources

MJFF Publications

5261 - 5270 of 7540 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • RESTRICTED
    Title: Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27342
    Citation Count: 43
  • RESTRICTED
    Title: Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.15252/embr.201744617
    Citation Count: 88
  • RESTRICTED
    Title: mGlu1 and mGlu5 modulate distinct excitatory inputs to the nucleus accumbens shell
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41386-018-0049-1
    Citation Count: 26
  • RESTRICTED
    Title: Detecting Motor Impairment in Early Parkinson’s Disease via Natural Typing Interaction With Keyboards: Validation of the neuroQWERTY Approach in an Uncontrolled At-Home Setting
    Journal Name: Journal of Medical Internet Research
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/jmir.9462
    Citation Count: 41
  • RESTRICTED
    Title: NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate
    Journal Name: Journal of Neuroscience Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/jnr.24230
    Citation Count: 18
  • RESTRICTED
    Title: Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-018-0977-0
    Citation Count: 55
  • RESTRICTED
    Title: Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27345
    Citation Count: 15
  • RESTRICTED
    Title: Age‐ and sex‐related heterogeneity in prodromal Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27349
    Best OA location URL:
    Citation Count: 27
  • RESTRICTED
    Title: Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following l-DOPA Administration in Hemi-Parkinsonian Rats
    Journal Name: Neurochemical Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11064-018-2514-y
    Best OA location URL:
    Citation Count: 12
  • RESTRICTED
    Title: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27361
    Citation Count: 133
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.